What's New

NIH Grant Opportunities Icy Hot Heat Therapy Products - Class II Recall Sponsorship Opportunity Expanded Fentanyl Patch Recall Duragesic Patch Recall FDA Safety Review Regarding Botox & Botox Cosmetic Avoiding Accidental Overdoses when Methadone is Prescribed for Pain The TMJA - Giving TMJ Patients A Voice Archives

My Profile

Update Profile Forgot Password? Register

"

First Time Visitor?

Did you know…over 10 million people in the U.S. suffer from TMJDs and 90% are women in their childbearing years!

TMJD Overview Common Treatments Self-care Tips Who Treats TMJDs? Questions You Should Ask We Get Questions & Comments

We Need You!                   Get Involved!

Donate Register with the TMJA Join TMJD Voices Campaign Write your Elected Officials Volunteer

Purpose of Meeting:

The Fifth Scientific Meeting of The TMJ Association focuses on conditions often found to be comorbid with temporomandibular joint and muscle disorders (TMJDs). These include chronic headache, generalized pain conditions, irritable bowel syndrome, endometriosis, interstitial cystitis, vulvodynia, fibromyalgia, chronic fatigue syndrome, and rheumatoid arthritis.

Educational Objectives:

The goal of the meeting is to discover if there are common roots and physiological pathways among these conditions, in this way furthering our understanding of all of them and perhaps providing novel targets for diagnosis and therapy. Because the meeting has been designed to bring together scientists and clinicians knowledgeable about each of the complex conditions named above, we hope to stimulate cross-collaborative studies as a means to accelerate research progress and ultimately benefit patients. Toward that end we have also invited young investigators to stimulate their career commitments to engage in TMJD and related research. As in past TMJ Association scientific meetings, patients themselves will participate in panel presentations and discussions, providing opportunities for experts and patients to learn from each other in formal and informal exchanges.

Who Should Attend:

Clinical and basic scientists, physicians, dentists and other health professionals, federal agency officials, patients and loved ones, and patient advocates for the comorbid conditions are encouraged to participate.

Topics:

Clinical Symptoms and Comorbidities of TMJD Patients
• Christian S. Stohler, D.M.D., Dr. Med. Dent., University of Maryland Dental School, Baltimore, MD
• Peter Svensson, D.D.S., Ph.D., Dr. ODONT., School of Dentistry, University of Aarhus, Denmark
• William Maixner, D.D.S., Ph.D., University of North Carolina at Chapel Hill, Chapel Hill, NC

Chronic Headache
• Richard B. Lipton, M.D., Albert Einstein College of Medicine, Bronx, NY
• Paul L. Durham, Ph.D., Missouri State University, Springfield, MO

Generalized Pain Conditions
• Christine N. Sang, M.D., M.P.H., Brigham and Women's Hospital, Harvard Medical School, Boston, MA
• Linda R. Watkins, Ph.D., University of Colorado at Boulder, Bolder, CO

Irritable Bowel Syndrome/Endometriosis/Interstitial Cystitis/Vulvodynia
• Emeran A. Mayer, M.D., University of California, Los Angeles, Los Angeles, CA
• Karen J. Berkley, Ph.D., Florida State University, Tallahassee, FL
• Larissa V. Rodriguez, M.D., University of California, Los Angeles, Los Angeles, CA
• Lori A. Birder, Ph.D., University of Pittsburgh School of Medicine, Pittsburgh, PA

Fibromyalgia
• Daniel J. Clauw, M.D., University of Michigan, Ann Arbor, MI
• Lesley M. Arnold, M.D., University of Cincinnati College of Medicine, Cincinnati, OH
• Jon. D. Levine, M.D., Ph.D., University of California-San Francisco, San Francisco, CA
• Dane B. Cook, Ph.D., University of Wisconsin-Madison, Madison, WI

Chronic Fatigue Syndrome
• Suzanne D. Vernon, Ph.D., The CFIDS Association of America, Charlotte, NC
• Nancy G. Klimas, M.D., University of Miami School of Medicine, Miami, FL

Rheumatoid Arthritis
• Joan M. Bathon, M.D., Johns Hopkins University, Baltimore, MD
• Alisa E. Koch, M.D., Veteran's Administration, Ann Arbor, Ann Arbor, MI, and the University of Michigan, Ann Arbor, MI

Temporomandibular Joint and Muscle Disorders
• Ke Ren, Ph.D., University of Maryland Dental School, Baltimore, MD
• Jon-Kar Zubieta, M.D., Ph.D., University of Michigan, Ann Arbor, MI
• David A. Bereiter, Ph.D., University of Minnesota School of Dentistry, Minneapolis, MN
• John T. Watson, Ph.D., University of California San Diego, La Jolla, CA

Continuing Education Credits

• Continuing Dental Education (CDE) - Meeting attendees are eligible for up to 12.25 hours of Continuing Dental Education. Attendance certification forms will be available at registration.
• Continuing Medical Education (CME)
  • Accreditation Statement - This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical College of Wisconsin and The TMJ Association. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
  • Designation of Credit Statement - The Medical College of Wisconsin designates this educational activity for a maximum of 12.25 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Program Committee:

• Allen W. Cowley, Jr. Ph.D., Medical College of Wisconsin, Milwaukee, WI (Chairman)
• Terrie Cowley, The TMJ Association, Milwaukee, WI
• Ronald Dubner, D.D.S., Ph.D., University of Maryland Dental School, Baltimore, MD
• Stephen L. Gordon, Ph.D., Gordon BioMedical Consulting, LLC, Carey, NC
• Christian S. Stohler, D.M.D., Dr. Med. Dent., University of Maryland Dental School, Baltimore, MD
• John T. Watson, Ph.D., University of California, San Diego, La Jolla, CA
  
  

Back to Top